These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37549799)

  • 1. Combining non-canonical amino acid mutagenesis and native chemical ligation for multiply modifying proteins: A case study of α-synuclein post-translational modifications.
    Galesic A; Pan B; Ramirez J; Rhoades E; Pratt MR; Petersson EJ
    Methods; 2023 Oct; 218():101-109. PubMed ID: 37549799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.
    Pan B; Kamo N; Shimogawa M; Huang Y; Kashina A; Rhoades E; Petersson EJ
    J Am Chem Soc; 2020 Dec; 142(52):21786-21798. PubMed ID: 33337869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-Based Mimic of Arginylation Reproduces Neuroprotective Effects of the Authentic Post-Translational Modification on α-Synuclein.
    Pan B; Shimogawa M; Zhao J; Rhoades E; Kashina A; Petersson EJ
    J Am Chem Soc; 2022 May; 144(17):7911-7918. PubMed ID: 35451816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic Semisynthesis of Phosphorylated α-Synuclein Enables Identification of a Bidirectional Effect on Fibril Formation.
    Pan B; Rhoades E; Petersson EJ
    ACS Chem Biol; 2020 Mar; 15(3):640-645. PubMed ID: 32065743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.
    Pancoe SX; Wang YJ; Shimogawa M; Perez RM; Giannakoulias S; Petersson EJ
    J Mol Biol; 2022 Dec; 434(23):167859. PubMed ID: 36270580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons.
    Ramalingam N; Dettmer U
    J Biol Chem; 2021; 296():100271. PubMed ID: 33428933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
    Chen H; Zhao YF; Chen YX; Li YM
    ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1992-2000. PubMed ID: 30481588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
    J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
    Bodner CR; Maltsev AS; Dobson CM; Bax A
    Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation and O-GlcNAcylation at the same α-synuclein site generate distinct fibril structures.
    Hu J; Xia W; Zeng S; Lim YJ; Tao Y; Sun Y; Zhao L; Wang H; Le W; Li D; Zhang S; Liu C; Li YM
    Nat Commun; 2024 Mar; 15(1):2677. PubMed ID: 38538591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity.
    Kim TE; Newman AJ; Imberdis T; Brontesi L; Tripathi A; Ramalingam N; Fanning S; Selkoe D; Dettmer U
    Hum Mol Genet; 2021 Nov; 30(23):2332-2346. PubMed ID: 34254125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.
    Levine PM; De Leon CA; Galesic A; Balana A; Marotta NP; Lewis YE; Pratt MR
    Bioorg Med Chem; 2017 Sep; 25(18):4977-4982. PubMed ID: 28487126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules.
    Karube H; Sakamoto M; Arawaka S; Hara S; Sato H; Ren CH; Goto S; Koyama S; Wada M; Kawanami T; Kurita K; Kato T
    FEBS Lett; 2008 Oct; 582(25-26):3693-700. PubMed ID: 18848547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
    Coskuner O; Wise-Scira O
    ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding.
    El Turk F; De Genst E; Guilliams T; Fauvet B; Hejjaoui M; Di Trani J; Chiki A; Mittermaier A; Vendruscolo M; Lashuel HA; Dobson CM
    Protein Sci; 2018 Jul; 27(7):1262-1274. PubMed ID: 29603451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein.
    Rospigliosi CC; McClendon S; Schmid AW; Ramlall TF; Barré P; Lashuel HA; Eliezer D
    J Mol Biol; 2009 May; 388(5):1022-32. PubMed ID: 19345692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease.
    He S; Wang F; Yung KKL; Zhang S; Qu S
    ACS Chem Neurosci; 2021 Apr; 12(7):1061-1071. PubMed ID: 33769791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state ¹³C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-Synuclein.
    Leftin A; Job C; Beyer K; Brown MF
    J Mol Biol; 2013 Aug; 425(16):2973-87. PubMed ID: 23583776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.